Efficacy and Safety of Eplerenone Compared to Enalapril in Left Ventricular Hypertrophy
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2002-03-31
著者
-
Roniker Barbara
Pharmacia Corporation
-
Krause Scott
Pharmacia Corporation
-
Krause Scott
Pharmacia Corporation Skokie Il
-
Roniker Barbara
Pharmacia Corporation Skokie Il
-
Barrios Alonso
Hospital Ramon Y Cajal Madrid Spain
-
Kleiman Jay
Pharmacia Corporation
-
Pitt Bertram
University of Michigan Medical School
-
Sobrino-Marlinez Juan
Hosupital de I'Espirit Sant,Bracelona,Spain
-
Zannad Faiez
Hopital Jeanne d'Arc
-
Kleiman Jay
Pharmacia Corporation Skokie Il
-
Zannad Faiez
Hopital Jeanne D'arc
-
Sobrino-marlinez Juan
Hosupital De I'espirit Sant Bracelona Spain
関連論文
- Comparison of Eplerenone and Losartan on Blood Pressure Lowering in Low-Renin Hypertension
- Evaluation of the Antihypertensive Efficacy of Eplerenone and Amlodipine in Older Patients with Systolic Hypertension
- Evaluation of the Eplerenone and Losartan in Patients with Hypertension
- Co-Administration of Eplerenone with an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin II Antagonist in Patients with Mild to Moderate Hypertension
- Antihypertensive Effect of Eplerenone and Enalapril in Patients With Essential Hypertension
- Antihypertensive Effect of Eplerenone Versus Amlodipine in Patients with Elevated Systolic Blood Pressure
- Efficacy and Safety of Eplerenone Compared to Enalapril in Left Ventricular Hypertrophy
- Treatment of Heart Failure(Mikamo Lecture,The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- The Role of Angiotensin Converting Enzyme Inhibitors (ACE-I), Angiotensin II Type I Receptor Antagonist (ARBs) and Aldosterone Receptor Blockers (AB) In Chronic Heart Failure (HF)